Analyst Ratings for BridgeBio Pharma (BBIO) [Neutrals]
BBIO Rating Summary
BBIO Price Target Summary
- Highest: $60.00 (Cantor Fitzgerald)
- Lowest: $33.00 (Jefferies)
- Average: $47.45
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$47.45 (+95%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Avg. $ Target:
$47.45 (+95%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/31/2024 | BMO Capital | Kostas Biliouris | New Coverage | Market Perform (N/A) |
37.00 (N/A) |
37.84 (24.33) |
-35.7% | Details |
| 7/18/2023 | Jefferies | Eun Yang | Downgrade | Hold (Buy) |
33.00 (24.00) |
18.22 (24.33) |
33.53% | Details |
